IN2013MU03123A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03123A
IN2013MU03123A IN3123MU2013A IN2013MU03123A IN 2013MU03123 A IN2013MU03123 A IN 2013MU03123A IN 3123MU2013 A IN3123MU2013 A IN 3123MU2013A IN 2013MU03123 A IN2013MU03123 A IN 2013MU03123A
Authority
IN
India
Prior art keywords
enzalutamide
amorphous form
relates
abstract
effective amount
Prior art date
Application number
Other languages
English (en)
Inventor
Shri Prakash Dhar Dwivedi
Kumar Kamlesh Singh
Brij Khera
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Priority to IN3123MU2013 priority Critical patent/IN2013MU03123A/en
Publication of IN2013MU03123A publication Critical patent/IN2013MU03123A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN3123MU2013 2013-09-30 2013-09-30 IN2013MU03123A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3123MU2013 IN2013MU03123A (es) 2013-09-30 2013-09-30

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3123MU2013 IN2013MU03123A (es) 2013-09-30 2013-09-30

Publications (1)

Publication Number Publication Date
IN2013MU03123A true IN2013MU03123A (es) 2015-07-17

Family

ID=54397188

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3123MU2013 IN2013MU03123A (es) 2013-09-30 2013-09-30

Country Status (1)

Country Link
IN (1) IN2013MU03123A (es)

Similar Documents

Publication Publication Date Title
PH12016500094A1 (en) Autotaxin inhibitors
EA033555B1 (ru) Фармацевтические композиции для лечения серповидно-клеточного нарушения
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
MY194495A (en) Compositions and methods for transmucosal absorption
MY181892A (en) Plinabulin compositions
PH12015501096A1 (en) Composition for immediate and extended release
WO2014203275A3 (en) An improved process for the preparation of apixaban and intermediates thereof
MY168212A (en) A new therapeutical composition containing apomorphine as active ingredient
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
UA116889C2 (uk) Фармацевтична композиція, що містить суміш ізоформ apg101 (cd95-fc)
IN2013MU03641A (es)
MX2016001422A (es) Composicion farmaceutica de fingolimod.
MX366829B (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
PH12015501377A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
MX2015010486A (es) Composicion masticable para administracion oral y proceso para preparar la misma.
IN2013MU01111A (es)
UA116994C2 (uk) Стабілізована аморфна форма агомелатину, спосіб її одержання і фармацевтичні композиції, які її містять
IN2013CH04314A (es)
UA105260C2 (ru) Фармацевтическая композиция для приготовления инфузионных растворов антимикробных препаратов, способ ее получения (варианты)
WO2014122671A3 (en) Solid oral compositions of saxagliptin
IN2013MU03123A (es)
IN2013MU01226A (es)